Source: StreetInsider

Press Release: Eli Lilly : OLUMIANT Improved Pain, Physical Function and Morning Joint Stiffness in Rheumatoid Arthritis in Phase 3 Post-Hoc Analyses

INDIANAPOLIS, June 1, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY)Â will present data from post-hoc analyses that...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
$25.5B
Employees
38,680
David A. Ricks's photo - Chairman & CEO of Eli Lilly

Chairman & CEO

David A. Ricks

CEO Approval Rating

65/100

Read more